Menu

#Mbiomics

1 post

Feed
1 of 1 post
mbiomics raises €30M Series A to take its microbiome cancer co-therapy into clinical trials
🖼️
0

mbiomics raises €30M Series A to take its microbiome cancer co-therapy into clinical trials

TNW | Health-Tech·Ana-Maria Stanciuc·about 1 month ago
#ThpMEBnV

The Munich techbio company is developing a live bacterial product designed to enhance immune checkpoint inhibitor response in advanced melanoma, with a Phase 1B study planned for 2027 mbiomics GmbH, a Munich-based techbio company developing…

15s
Read More